TP53 and B-cell chronic lymphocytic leukemia: In this study, we developed an RT-MLPA-assay that included genes differentially expressed upon irradiation between (i) WT and TP53/ATM-mutant CLL, and between (ii) TP53-mutant and ATM-mutant CLL.